All articles by Staff Writer
Staff Writer
Noul, a top On-Device AI healthcare company, joins CancerX, a cancer-fighting project led by the U.S. White House
As part of the Cancer Moonshot initiative announced at the White House, noul is delighted to announce its groundbreaking participation as a leading On-Device AI healthcare company in the private-public partnership, CancerX. Congratulations on noul’s efforts to take a step closer to global cancer conquest!
Sentara taps RhythmX AI to improve primary care with generative AI
The collaboration will focus on developing a next-generation, hyper-personalised primary care model for clinicians and patients.
BD Partners with Camtech Health to Increase Access to Cervical Cancer Screening in Singapore
First-Ever Program in the Country to Offer At-Home Self-Collection of Samples for HPV Testing
AZmed Secures €15 Million to Shape the Future of Medical Imaging with AI
AZmed, a leading European MedTech startup, has secured €15 million in Series A funding. The operation includes investors such as Maison Worms, Techstars, and Tempact Ventures. The investment supports AZmed’s overarching objective of shaping the future of medical imaging with artificial intelligence by accelerating the workflows of radiologists.
Thermo Fisher Scientific Launches New Ion Chromatography Instrument to Improve Reliability, Efficiency, and Functional Adaptability for Labs
New Thermo Scientific Dionex Inuvion Ion Chromatography System streamlines ion analysis and expands analytical testing capabilities for ionic and small polar compounds
Thermo Fisher Scientific Expands GMP Laboratory Service Offerings with Biosafety Testing Including Mycoplasma Testing
PPD clinical research business provides lab customers a comprehensive solution to help ensure safe medicines for patients
Revvity Signals Software Unveils Signals Clinical Solution to Accelerate Critical Clinical Trial Insights and Data-Driven Decisions
Today, Revvity, Inc. (NYSE: RVTY) announced that its software and informatics division, Revvity Signals, is unveiling the Signals ClinicalTM solution, a software-as-a-service (SaaS), end-to-end clinical data science platform designed to centralize all clinical trial data, providing fast, actionable insights for quicker clinical decisions and accelerated market delivery of therapeutics. This state-of-the-art solution, when integrated with enterprise-class Spotfire visual analytics, has the potential to redefine how the pharmaceutical, biotechnology, and contract research industries approach clinical trial data, offering an unprecedented level of access and insight to drive forward clinical development and therapeutic innovations.
Freudenberg Medical Establishes Second Production Facility in Costa Rica
Freudenberg Medical, a global contract design and manufacturing (CDMO) partner to the medical device and biopharma industry with facilities in key industry hubs across the Americas, Europe and Asia, announced it is to establish a second manufacturing site in Costa Rica. With this $25 million investment the company is expanding its technologies to deliver increasingly complex products to its global customer base.
Lumos Appoints Henry Schein as US Distributor for FebriDx®
Lumos Diagnostics (ASX: LDX), (“Lumos” or the “Company”) a leader in rapid, point-of-care diagnostic technologies, has signed an agreement with Henry Schein, Inc. (Nasdaq: HSIC) to distribute FebriDx® in the United States (US).
Revvity Showcases Cutting-Edge Solutions at SLAS2024
Propelling Diagnostics and Life Sciences Innovation from Early Phase Research to the Clinic: Revvity Showcases Cutting-Edge Solutions at SLAS2024